Literature DB >> 26760196

Hydrogen sulfide prevents OGD/R-induced apoptosis by suppressing the phosphorylation of p38 and secretion of IL-6 in PC12 cells.

Chong Li1, Yue Liu, Peng Tang, Peng Liu, Chen Hou, Xin Zhang, Li Chen, Lina Zhang, Chaochao Gu.   

Abstract

Hydrogen sulfide (H2S), a well-known endogenous mediator, has been shown to exert protective effects against neuronal damage caused by brain ischemia, but the mechanism of its action remains unclear. We have reported the neuroprotective properties of H2S against oxygen-glucose deprivation/reoxygenation (OGD/R)-induced injury by inhibiting the phosphorylation of p38. The present study evaluates the effect of H2S on OGD/R-induced cell injury or apoptosis and the mechanisms for its action in PC12 cells. Pretreatment of PC12 cells with exogenous sodium hydrosulfide (NaHS) (a H2S donor, 100 or 300 µM) for 12 h before exposure to OGD/R markedly attenuated p38 phosphorylation. Activation of p38 MAPK by transfection of activated p38α, but not p38β, reversed the protective effect of NaHS, as measured by enzyme-linked immunosorbent assay analysis. Importantly, SB203580 (a p38 MAPK inhibitor) also reversed the protective effects of p38α-activated p38 MAPK. Interleukin-6 secretion after OGD/R decreased significantly with NaHS compared with without NaHS. Taken together, we show that the p38 pathway contributes toward OGD/R-induced cell death and p38α plays a key role in OGD/R-induced interleukin-6 secretion.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26760196     DOI: 10.1097/WNR.0000000000000522

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  7 in total

Review 1.  Cross-talk of MicroRNA and hydrogen sulfide: A novel therapeutic approach for bone diseases.

Authors:  Yuankun Zhai; Suresh C Tyagi; Neetu Tyagi
Journal:  Biomed Pharmacother       Date:  2017-06-10       Impact factor: 6.529

2.  Exploring the model of PC12 apoptosis induced by OGSD/R through in vitro experiments.

Authors:  Yanqing Sun; Wei Zhu; Shengyuan Zhou; Zhiwei Wang; Xiongsheng Chen; Lianshun Jia
Journal:  Oncotarget       Date:  2017-10-04

Review 3.  Neuroprotective Effects of Bioactive Compounds and MAPK Pathway Modulation in "Ischemia"-Stressed PC12 Pheochromocytoma Cells.

Authors:  Adi Lahiani; Annette Brand-Yavin; Ephraim Yavin; Philip Lazarovici
Journal:  Brain Sci       Date:  2018-02-08

4.  The Protective Effects of Hydrogen Sulfide New Donor Methyl S-(4-Fluorobenzyl)-N-(3,4,5-Trimethoxybenzoyl)-l-Cysteinate on the Ischemic Stroke.

Authors:  Jing Fan; Junxi Du; Zhongwei Zhang; Wenjing Shi; Binyan Hu; Jiaqin Hu; Yan Xue; Haipeng Li; Wenjin Ji; Jian Zhuang; Pengcheng Lv; Kui Cheng; Kun Chen
Journal:  Molecules       Date:  2022-02-25       Impact factor: 4.411

5.  Dexmedetomidine attenuates oxygen-glucose deprivation/ reperfusion-induced inflammation through the miR-17-5p/ TLR4/ NF-κB axis.

Authors:  Liangyuan Suo; Mingyu Wang
Journal:  BMC Anesthesiol       Date:  2022-04-29       Impact factor: 2.376

Review 6.  Mechanisms by which hydrogen sulfide attenuates muscle function following ischemia-reperfusion injury: effects on Akt signaling, mitochondrial function, and apoptosis.

Authors:  Michael D Wetzel; Joseph C Wenke
Journal:  J Transl Med       Date:  2019-01-21       Impact factor: 5.531

7.  Activation of p38 MAPK participates in the sulbactam-induced cerebral ischemic tolerance mediated by glial glutamate transporter-1 upregulation in rats.

Authors:  Xiao-Hui Xian; Jun-Xia Gao; Jie Qi; Shu-Juan Fan; Min Zhang; Wen-Bin Li
Journal:  Sci Rep       Date:  2020-11-26       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.